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ABSTRACT. Anticancer potentiality of some newly synthesized Nano-Biginelli compounds with the help of 
enzyme extracted naturally from plants is reported. The biological synthesis of nanoparticles via nano 
biotechnology processes have a significant potential to enhance the production without the use of harsh, toxic, and 
expensive chemicals commonly used in conventional physical and chemical processes. The compounds have been 
characterized on the basis of UV, FTIR, XRD and SEM studies in order to depict the formation of nanoparticles. Using 
the combination of docking and ADMET techniques, we have tried to predict the anti-cancer potentiality as well 
as its area of target, i.e. cancer cell to trigger the anti-cancer reaction. Results indicate that the compound 1 (ethyl-
6-methyl-2-oxo-4-(4-methoxyphenyl)-1,2,3,4-tetrahydropyrimidin-5-carboxylate) has possible virtual leads to 
design novel human Aurora B kinase inhibitor. 
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INTRODUCTION 
 
Nanotechnology is the creation, manipulation and use of materials at the nanometer size scale (1 
to 100 nm). There is a tremendous growth in the field of nano science and nanotechnology over 
the past two decades. Nanomaterials have numerous applications in the field of electronics, 
cosmetics, coatings, packaging and biotechnology [1]. There are several reports in the literature 
[2-6] which show an amazing level of their performance as catalysts in terms of selectivity, 
reactivity and improved yields of products.  
In addition, the high surface-to-volume ratio of nanoparticles provides a larger number of 
active sites per unit area compared to their heterogeneous counterparts. Catalysis by transition 
metal nanoparticle has undergone an explosive growth during the past decade [7]. Recyclability 
is one of the most important properties of nanoparticles which make chemical synthesis 
ecofriendly green protocol. Nano catalyst can be easily reused and recycled for numerous cycles 
with unswerving activity. 
Even though metal nanoparticles are being increasingly used in many segments of the 
economy, there is growing interest in the biological and environmental safety of their 
production. The main methods for nanoparticle production are chemical and physical 
approaches that are often costly and potentially detrimental to the environment. Thus, there is a 
great need for an alternative, cost-effective and at the same time safe and environmentally sound 
method of nanoparticle production. Although nanoparticles can be synthesized by various 
traditional methods, it is now possible to biologically synthesize these materials via 
environment-friendly green chemistry based techniques.   
In recent years, the convergence between nanotechnology and biology has created the new 
field of nano biotechnology that incorporates the use of biological entities such as actinomycetes 
[8], algae, bacteria [9], fungi [10], viruses [11], yeasts, and plants [12] in a number of 
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biochemical and biophysical processes. To improve nanoparticles production without the use of 
harsh, toxic, and expensive chemicals commonly used in conventional physical and chemical 
processes, currently biological synthesis via nano biotechnology has been used [13].  
Biosynthesis of nanoparticles by means of plants or plant based extracts tends to be safe, have 
relatively short production times, and a lower fabrication cost compared to other biological 
systems. 
Among heterocyclic compounds, 3,4-dihydropyrimidinones (Biginelli compounds) [14] 
are highly contained in organic synthesis due to their attractive pharmacological properties, 
including calcium channel blockers, antihypertensive agents, α-1a-antagonists, HIV gp-120-
CD4 inhibitors (crambine and betzellidine alkaloids), antiviral, antitumour, antibacterial 
activities and neuropeptide Y(NPY) antagonists.  
Hence, in continuation to our interest on the synthesis of  heterocyclic compounds  by 
green protocols and provoked by the diverse biological activities associated with Biginelli 
compounds, we now synthesize some novel Nano-Biginelli compounds with the help of 
enzyme extracted naturally from the plant. Compounds have been characterized on the basis 
of UV, FTIR, XRD and SEM in order to depict the formation of nanoparticles and determination of 
their size and shape.  
EXPERIMENTAL 
 
Reagents and solvents were purchased from commercial sources and used without further 
purification. Melting points were determined on a Toshniwal apparatus. The purity of 
compounds was checked on thin layers of silica gel in various non-aqueous solvent systems, e.g. 
benzene : ethyl acetate (9:1), benzene : ethyl acetate : methanol (8.5:1.4:0.1). UV-Visible 
spectra were recorded on UV1800S, Shimadzu, Japan. IR spectra of the synthesized compounds 
1 and 2 were recorded in KBr on a Perkin Elmer Infrared RXI FTIR spectrophotometer and 1H 
NMR spectra were recorded on Bruker Avance II 400 NMR Spectrometer using DMSO-d6 and 
CDCl3 as solvent and tetramethylsilane (TMS) as internal reference standard. Horse gram seeds 
(Macrotyloma uniflorum) were collected from departmental store, Hyderabad. Fourier 
transforms infrared spectroscopy (FTIR) study of the nanoparticles was performed on 
Shimadzu, Japan, using KBr as a reference. 
Synthesis of Biginelli compounds compound 1 and compound 2 were synthesized following 
the literature method [15] and characterized using spectral analysis.    
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Synthesis of green Nano-Biginelli compounds  
 
Biosynthesis of nanoparticles using plants or plant based extracts is safe and have relatively 
short production times as well as lower production cost compared to other biological systems. 
For the synthesis of green nanoparticles, Horse gram seeds extract is used. The first step in the 
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synthesis of green nanoparticles is the collection of black coated horse gram seeds (Figure 1a). 
The next step is the germination of seeds (Figure 1b) for which the seeds were washed with 
KMnO4 solution. After washing, the seeds were soaked in distilled water for about 12 hours. 
The seeds were alllowed to germinate and they were moistened with distilled water regularly for 
every 12 hours. The germinated seeds are freeze dried and are grounded to 60 mesh size in 
acetone. The mixture obtained was filtered through double layer whatmann filter paper number 
1. The dry homogenate was coarsely ground using motar and pestle and the powder was then 
suspended in the phosphate buffer solution. This mixture was further filtered and centrifuged at 
10000 rpm for 8 min below 4 oC and the supernatant  collected contains enzyme, protease which 
was mixed with the synthesized Biginelli compounds compound 1 and compound 2. After 2-3 
days, compounds were converted into nano particles. 
 
 
     Figure 1a.  Horse gram seeds.                                         Figure 1b.  Germinated seeds.    
 
Characterization of Nano-Biginelli compounds  
 
The newly synthesized nanoparticles were characterized by using UV-Visible spectra, FTIR 
(Fourier transform infrared spectroscopy), XRD (X-ray diffraction) and SEM (scanning electron 
microscopy). 
 
 
 
Figure 2. UV-Visible absorption spectra of compound 2 nanoparticles. 
 
UV-Visible spectroscopy  
 
UV-Visible absorption spectra of compound 2 nanoparticles (Figure 2) indicates that a band 
due to the >C=N chromophore in the spectrum of the compound at 285 nm shifts to a higher 
wavelength. Such a shift in n- π* transition band is probably due to the donation of a lone pair 
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of electrons by the nitrogen. Further, two bands at 260 nm and 305 nm are due to π-π* 
transitions which are assigned to the benzenoid ring and (NH) band of the pyrimidine ring 
respectively. The K band π-π* showed a red shift due to the increase in conjugation and the B-
band undergoes a hypsochromic shift. 
 
Fourier transforms infrared spectroscopy  
 
A 0.25 g dried sample (compound 2 nanoparticles) was mixed with KBr (sample/KBr ratio 
was 1/100) and pressed into the transparent thin pellet.  
 
X-Ray powder diffraction of nanoparticles 
 
Powder X-ray diffraction patterns of the prepared sample were taken by a two-circle (2q-q).  
X-ray powder diffractometer (X'Pert PRO XRD PW 3040 system) using Copper kα1 of 
wavelength 1.54056´10-10 m, and kα2 of wavelength 1.544426´10-10 m. The scan was taken 
between 2θ of 10° and 2θ of 71.89° at increments of 0.04° with a count time of 4 seconds for 
each step (Figure 3).  
 
 
Figure 3.  XRD pattern of compound 2 nanoparticles.  
 
 
 
Figure 4a. SEM of compound 1 nanoparticles.        
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Figure 4b. SEM of compound 2 nanoparticles. 
 
RESULTS AND DISCUSSION 
 
Biginelli reaction is an important multicomponent reaction for the formation of Biginelli 
compounds. The classical Biginelli reactions were conducted under strongly acidic conditions, 
which suffer from various drawbacks like poor yields, long reaction times, and sensitive 
functional groups are lost during the reaction conditions. This has led to the development of 
several new methodologies, which improve the yields compared to the original procedure. These 
new strategies involve the use of following catalysts, e.g. BF3*OEt2, montmorillonite (KSF), 
polyphosphate esters and reagents like LiBr [16], TMSCl/NaI [17], LaCl3.7H2O [18], 
CeCl3.7H2O [19], Mn(OAc)3.2H2O [20], FeCl3 and HCl [21], ytterbium triflate [22], iodine [23], 
ZnCl2 [24], CoCl2 [25], etc. We have synthesized Biginelli compounds compound 1 and 
compound 2 using our reported literature method and converted these Biginelli compounds to 
Nano-Biginelli compounds with the help of enzyme extracted naturally from plants.  
In recent years, plant mediated biological synthesis of nanoparticle is achieving significance 
due to its consistency and eco-friendliness [26]. Horse gram scientifically known as 
Macrotyloma uniflorum is widely consumed as staple diet in Southern parts of India. Other 
name variations of Horse gram are Kulthi bean, Madras gram, Hurali and Horse gram. It plays 
an important role in the inhibition/dissolution of calcium oxalate and gallbladder stone. 
Medicinal values and edibility of the pulse are already established [27]. Horse gram seed 
extracts contain enzyme protease which was mixed with the synthesized Biginelli compounds 
compound 1 and compound 2. After 2-3 days, compounds were converted into nano particles. 
There is no report available in the literature regarding the synthesis of  green Nano-Biginelli 
compounds. Further, the nanoparticles have also been characterized using UV, FTIR, XRD and 
SEM images and  prediction of the anticancer potentiality of Biginelli nanoparticles is being 
carried out by molecular docking and ADMET techniques. 
FTIR spectrum was obtained in the range 3242 to 781 cm-1 indicating  peaks at 3242 cm-1 
(m)  for N-H stretch, 1722 cm-1 for C=O stretch, peaks at 1645 and 1600 cm-1 for C=C stretch in 
the aromatic compounds. A very weak peak at 1630 cm-1 is also observed for C=C aromatic 
stretch and peaks at 1462, 1388 and 2980 cm-1 indicate the C-H bend in CH3 and CH2, 1091 cm
-1 
for C-O-C of ethyl and pyrimidine ring and  at 781 cm-1 is for C-Cl stretch.  
The XRD spectrum of compound 2 nanoparticles in Figure 3 shows that there are two Bragg 
diffraction peaks at near 2θ = 12.68o and 23.17o. The present study, the peaks at near 2θ = 12.68o 
and 23.17o correspond to the presence of large amounts of amorphous compound 2 Nano-
materials in association with cubic lattice system [28]. 
SEM images of compound 1 and compound 2 nanoparticles in the range 180-300 nm 
indicating the formation of nanoparticles (Figure 4). 
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Protein preparation  
 
The human DNA topoisomerase I protein structure complexed with Camptothecin is retrieved 
from the PDB database (PDB ID: 1T8I) having a resolution of 3.0 Å and is imported into 
Accelrys Discovery Studio 2.1. Further using the clean protein protocol within Discovery 
Studio, the protein is prepared for correcting the lack of hydrogen atoms, missing atoms and 
residues, incorrect atom order in amino acids, to complete the protein chain. Water molecules 
are removed, and protonating all the residues at a pH of 7.4 is done thus allowing the 
protonation of arginine and lysine side chains and deprotonation of glutamate and aspartate 
side chains. The protonation of histidine side chains is selective in accordance with their 
context in the target. All the heteroatoms are removed except Camptothecin, which is used 
later for defining the binding site. To the entire protein complex of human DNA 
topoisomerase I and Camptothecin, CHARMm force field is applied for protein preparation 
with potential energy of -16901.16 kcal/mol, Van der Waals energy of -1848 kcal/mol and an 
initial RMS (root-meansquare) gradient energy of 0.2428 kcal/mol. By using smart minimizer 
algorithm with a maximum number of steps 1000 and RMS gradient 0.1, energy minimization 
is performed that carry forward using steepest descent and conjugate gradient algorithm till the 
protein complex (Figure 5). 
 
 
Figure 5. Human DNA Topoisomerase I (70 kda) in complex with the poison camptothecin. 
 
Preparation of ligand dataset 
   
The synthesized compounds compound 1 and compound 2 were drawn using 
ACD/ChemSketch (12.0), the two-dimensional structures of all the compounds are drawn and 
saved in mol file format, later imported in to discovery studio and energy minimization carried 
out through appliance of smart minimizer algorithm with a maximum number of steps 1000 
and RMS gradient 0.1 which continues by steepest descent and conjugate gradient algorithm 
until the compounds are satisfied with a convergence gradient of 0.001 kcal mol-1. Further 
diverse conformations for each ligand are generated using DS diverse conformation generation 
module which employs the Poling algorithm. A maximum of 255 conformations are created 
per compound using FAST conformer method in reach of an energy range 20 kcal/mol over 
the global energy minimum. This preferred maximal value of conformations ensures an 
adequate inclusion of conformational space. Default settings are kept for the other parameters. 
 
Define binding site  
 
After the protein complex is energy minimized, by using Define and Edit Binding Site tools in 
Accelrys Discovery Studio 2.1 the binding site of the human DNA topoisomerase I is 
predicted. The protein binding site was determined based on the occupied volume of the 
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known ligand Camptothecin in the active site. The co-crystallized Camptothecin molecule is 
first selected, and a sphere is created around the molecule using define sphere from the 
selection option. A sphere is defined around the residues comprising binding site at a radius of 
10 Å. 
 
Molecular docking studies (docking strategy) 
 
For accurate docking of our synthesized compounds into active site of the protein, molecular 
docking is carried out through LibDock module in Accelrys Discovery Studio 2.1. LibDock is 
a high-throughput site-featured docking algorithm. The binding site features are called as 
‘hotspots’ in which these site spheres are resolved with a grid fixed in active site. It counts the 
hotspot map for polar and apolar cluster in the active site of the protein which is further used 
for the alignment of the ligand conformations to the interaction sites of the protein for the 
formation of considerable interaction. Finally, it returns all the minimized ligand poses and 
their rankings based on the ligands score. In accordance with the LibDock score, each pose is 
assessed which uses a simple pair-wise method. For estimating binding energies of the 
protein–ligand complex, the ligands with high LibDock scores are preferred. The complex 
pose with the best binding energy is used for further binding mode analysis. For the docking 
validation, the co-crystallized ligand Camptothecin in the human DNA topoisomerase I 
binding site is redocked. The binding affinities of the synthetic compounds were compared 
and analyzed in reference to Camptothecin to identify structural characteristics of the 
complexes formed by these compounds and the protein. 
 
ADMET studies  
 
ADMET (absorption, distribution, metabolism, excretion and toxicity) analysis is done using 
Accelrys Discovery Studio 2.1 which accommodates the awareness of the pharmacokinetic 
properties of the synthesized compounds. ADMET properties include absorption, blood–brain 
barrier (BBB), aqueous solubility, hepatotoxicity, plasma protein binding (PPB) and 
cytochrome [29, 30]. 
 
Docking studies  
 
To study the binding modes and affinities of our synthesized compounds with human DNA 
topoisomerase I (PDB ID: 1T8I), docking studies are carried out using LibDock. The best 
ligand conformation is selected on the basis of LibDock score and highly interacting amino 
acid residues. Of the ten conformations generated for each compound, compound 2 with the 
highest LibDock score is taken for interaction analysis of the hydrogen bonding. LibDock 
scores of all the compounds along with their hydrogen bond interactions and bond lengths are 
depicted in Table 1. From the overall docking and interaction analysis, the best conformation 
of the compound 2 docked complex shows high LibDock score of 134 kcal/mol and forms 
three hydrogen bonds with the protein human DNA topo I. Figure 6a depicts the hydrogen 
bond interactions of the enzyme human DNA topo I with the compound 2. Hydrogen bonds 
are formed between the N14 of compound 2 interacting with the oxygen atom of the OP1:D 
G12 (compound 2 : N14 - C:DG12:OP1) with a hydrogen bond distance of 2.793 Å, two  
hydrogen bonds formed in between Thr718 with N13 of compound 2 with distance 2.650 Å 
and 2.051 Å. Another hydrogen bond formed with NH2 of Arg 364 with O18 of compound 2 
with a distance of 3.038 Å [31].  
The hydrogen bond formations are represented in green-dotted lines and compound 2 is 
represented in ball-stick manner. The hydrogen bond formations are represented in green-
dotted lines and compound 1 is represented in ball-stick view (Figure 6b). 
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Table 1. Docking scores of the compounds. 
 
Compound Libdock 
score 
Interacting  
residues 
Interacting residues H-Distance 
Compound 1 123.045 
ARG364 
THR718 
TGP11 
DT10 
Asp722 
DG12 
DC112 
DA113 
Asp533 
A:ARG364:HH22- Compound 05:O19 
A:THR718:HG1 – Compound 05:N14 
Compound 05:H30 - A:THR718:OG1 
Compound 05:H31 - A:THR718:OG1 
Compound 05:H32 - C:TGP11:O4' 
 
 
 
2.051000 
2.121000 
2.169000 
1.949000 
1.344000 
Compound 2 134.284 
ARG364 
THR718 
TGP11 
DT10 
Asp722 
DG12 
DC112 
DA113 
Asp533 
Compound 06:N14 - C:DG12:OP1 
A:ARG364:NH2 – Compound 06:O18 
Compound 06:N13 - A:THR718:OG1 
Compound 06:N13 - A:THR718:OG1 
 
 
     
2.793000 
3.038000 
2.650000 
2.051000 
 
 
 
 
Figure 6a. Hydrogen bond interactions of a compound 2 with human DNA topo I (PDB 
ID:1T8I).  
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Figure 6b. Hydrogen bond interactions of a compound compound 1 with human DNA topo I 
(PDB ID:1T8I).  
 
ADMET results  
 
The compounds are further examined for their pharmacokinetic and toxicity studies using 
ADMET descriptors analysis protocol in Discovery Studio [32]. Using the standards provided 
by Discovery Studio, the results are analyzed. The calculated parameters are tabulated in Table 
2. According to the Discovery Studio parameters, standard analysis value like level 0 for human 
intestinal absorption, level 3 and level 4 for solubility, level 0 for non-inhibitory property with 
CYP450 2D6, level 3 for BBB penetration and level 0 for non-toxicity was filtered for obtaining 
drug-like compounds. BBB penetration and level 0 for non-toxicity was filtered for obtaining 
drug-like compounds. Figure 7 shows the plot of predicted values of drug absorption for our 
compounds. ADMET descriptors, the 2D polar surface area (PSA_2D) in A2 per compound is 
plotted against their consonant estimated atom-type partition coefficient (ALogP98). 
 
Table 2. Absorption, distribution, metabolism, excretion and toxicity. 
 
Compound ADMET_BB
B_ Level 
ADMET_Abs
orption_ Level 
ADMET_Solub
ility_ Level 
ADMET_Hepato
toxicity 
ADMET_C
YP2D6 
Compound 1 3 0 2 0 0 
Compound 2 3 0 3 1 0 
 
Finally, the ADMET studies deal with in silico prediction of the adverse effects of the 
synthesized compounds. These properties such as absorption, distribution, metabolism, 
excretion and toxicity (ADMET) are important in order to determine the success of the 
compound for human therapeutic use. The results were compared to the reference level values 
of Discovery Studio to analyze the properties of our compounds. The absorption levels 
(human intestinal absorption) of both the compounds are predicted to be having good 
absorption. Intestinal absorption is defined as a percentage absorbed rather than as the ratio of 
concentrations. The solubility levels of the compounds were in the range of 2–3, indicating 
good solubility for the compounds having the value 3 and less soluble for the compounds 
having the value 2. Both the compounds exhibited in silico cytochrome p4502D6 inhibition. 
Similarly, both the compounds are satisfactory with respect to CYP2D6 value as 0, suggesting 
that these compounds should be non-inhibitors of CYP2D6. In principle, cytochrome 
p4502D6 is involved in the metabolism of a variety of substrates in the liver and its inhibition 
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by a drug constitutes major cases of drug–drug interactions. The partial plasma binding ability 
of the compounds influences the efficacy of the drug, since the bound fraction is temporarily 
shielded from metabolism and only the unbound fraction exhibits pharmacological effects. 
Finally, the plasma protein binding property prediction denotes that both of them have binding 
C95% indicating that compounds have good bioavailability and are not likely to be highly 
bound to carrier proteins in the blood. Further, both the compounds have been predicted to 
have the probability hepatotoxicity levels less than 1. 
 
 
 
Figure 7. Plot of PSA versus log P for candidate compounds showing the 95 and 99% 
confidence limit; ellipses corresponding to the blood–brain barrier and intestinal 
absorption models. 
CONCLUSION 
 
Biological green synthesis of novel Biginelli-Nanoparticles is successfully achieved which is 
one of the environment-friendly green chemistry based techniques. ADMET studies indicate 
that absorption levels (human intestinal absorption) of both the compounds are predicted to be 
having good absorption. Both the compounds exhibited in silico cytochrome p4502D6 
inhibition. Similarly, both the compounds are satisfactory with respect to CYP2D6 value as 
zero, suggesting that these compounds should be non-inhibitors of CYP2D6. Combining the 
results of molecular docking, pharmacophore and ADMET studies, we have found that the 
compound 1 (ethyl-6-methyl-2-oxo-4-(4-methoxyphenyl)-1,2,3,4-tetrahydropyrimidin-5-
carboxylate) has all qualities to leads as a newest human Aurora B kinase inhibitor.  
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